TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Preoperative functional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Natural history of 5q SMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Successful Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of home-based rehabilitation program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bystander defibrillation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: recurrence rate of anal fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cervical Range of Movement (CROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival three years after end of therapy
Endpoint domain: Mortality/survival
Primary endpoint: First occurrence of coronary heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 10-meter walking test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events from Day 1 to 29
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Care Utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Compound outcome index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficacy of epidural block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucosal healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fMRI Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma polyphenol metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of maintenance low-pressure pneumoperitoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Muscle Thickness Measurement With Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum inspiratory and expiratory oral pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endoscopic Classification System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in participant's pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete evacuation rate of the products of conception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline dynamic degrees of ankle dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intensity of suicidal urges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in ratings of anhedonia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in ratings of sexual function
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in Blood Oxygen Level Dependent (BOLD) Signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to Work/Duty - Metabolic Equivalent for Tasks (METs) Score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: CAPS-5 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological measures of functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Regression of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparative GMT of neutralizing antibody to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GMT of SARS-CoV-2 RBD-binding antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with ≥4-fold rise in neutralizing antibody to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor grade diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: T-shirt Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Trunk Control Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency from the time of cerclage procedure to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: American Shoulder and Elbow Surgeons Scale (ASES)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: changes in pain experience (interference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Platelet transfusion refractoriness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in the volume of attachments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attachments failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in questionnaire's answers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Circadian rhythm deregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time between infection recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Re-operation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recurrent free survival
Endpoint domain: Mortality/survival
Primary endpoint: Count of Patients with Co-Prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of Prescribers Checking PMP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in migraine pain/severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Progression-free survival rate (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients who achieved etiological diagnosis of opportunistic fungal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of hospitalized patients who achieved clinical remission or cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of healthcare use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with gaps in care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: distress status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-management status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phenylalanine concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in WOMAC score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Circulating Ovarian Hormone: Estrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circulating Ovarian Hormone: Progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Whole Brain Glutamate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nicotine Metabolite Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average DRG volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 days Mortality in ICU
Endpoint domain: Mortality/survival
Primary endpoint: Re-Sentinel Lymph node harvesting rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MRS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infarct size/Left Ventricular mass%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The incidence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to complete clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glare related to microscope light
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics: Area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent adverse events (TEAEs) and serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Dimension of cervical intervertebral foramen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Scarring severity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: tlast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: markers of bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in the level of actigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Identification of COVID positive or negative patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability of ctDNA to detect Ovarian Cancer recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Eating disorder symptoms post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to medical therapy in Ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Impact of Swallowing Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Oswestry Disability Index (ODI) or Neck Disability Index (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vertical jump (power)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agility t-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Middle cerebral artery mean velocity (MCAV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Middle cerebral artery mean velocity reactivity to carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DNP conversion flux (pyruvate-to-lactate conversion rate; Kpl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DNP conversion flux (area under the curve; AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical 18FDG PET standardized uptake values (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of effective mouth-to-mouth ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum safe and tolerated dose of Levetiracetam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Fatigue Impact Scale (MFIS) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Maternal BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients that develop Postoperative Delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Viability of endometrial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression to use of ECMO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in percent days drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol problem severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of usable data collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concordance between Cellvizio pictures and pathology incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to cessation of new lesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Bioavailability Based on AUC0-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Bioavailability Based on AUC0-inf
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental adjustment to cancer
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Area under the concentration-time curve of nintedanib in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of nintedanib in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of pirfenidone in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of pirfenidone in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTO crossing of the targeted chronic total occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CapBuster System related clinically significant events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Changes in Omega-3 Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Changes in omega 3 to omega 6 ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of ablation-related esophageal thermal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean Age-standardized Annual Incidence of Metastatic Melanoma
Endpoint domain: Mortality/survival
Primary endpoint: Blood pressure reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to open eyes after anesthetics withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Ulcer Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in walking behavior (steps)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in walking behavior (step timing)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: salivary counts of Streptococcus mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: salivary counts of Lactobacillus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: High-Sensitivity C-Reactive Protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Assessment of Treatment Satisfaction (PGATS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Numerical Rating Scale-11 (NRS-11)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Disease Progression to CIN3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: glucose at 120 mins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: occurrence of solicited local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: occurrence of unsolicited local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: nature, frequency and severity of adverse events associated with the vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical examination by Sinclair scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment by VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of Long COVID syndrome occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of SARS-CoV-2 infection occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Marital adjustment
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Dementia Literacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in reflective total nasal symptom score (rESN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful infusion of CD22CART
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient-reported health-related quality of life (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient-reported health-related quality of life (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-reported health-related quality of life (KCCQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient pain scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patient total opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Experienced health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completeness of screening for spinal muscular atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between frequency of LAMS-occlusion and concomitant PPI-intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the clinical relevance of LAMS-occlusion and LAMS-occlusion-related complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of the clinical management of LAMS-occlusion in the respective participating centers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in temperature between two feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of haemarthrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of automatic segmentation with operative findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of the right atrial J-shape XFINE endovascular passive lead
Endpoint domain: Adverse events/effects
Primary endpoint: Electrical performances of the right atrial J-shape XFINE endovascular
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing level (decibel)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The ratio of distortion product otoacoustic emission (DPOAE) failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of occlusions of intercostal chest catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receptivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional shoulder constant score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional shoulder ases score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival (OS) at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Change in patient's accessibility to care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in patient's understanding of their disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in medication compliance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in overall patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Submaximal Exercise Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-Year depression severity score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in breakup pattern to appear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in lipid coverage of the cornea with blinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in consistency of lipid compensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes